Searched for
DRAFT NPPP
Indian pharma market to grow at 15.3 pc CAGR by FY14The growth rate for the domestic Indian pharmaceutical market is set to rise over medium-term.- GoM on drug pricing defers decision, next meet on FridayGoM headed by Sharad Pawar tasked with the mandate to finalise the country's drug pricing policy heard the views of industry bodies stakeho...
- A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcareThe debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies.
- GoM on drug pricing defers decision
- GoM on drug pricing to meet todayA panel of ministers will meet on Wednesday to discuss the formula to cap the retail prices of 348 essential drugs and their combinations.
- GoM may decide drug pricing policy on WednesdayA panel of ministers will meet on Wednesday to decide the formula to cap the retail prices of 348 essential drugs and their combinations.
- National Pharmaceuticals Pricing Policy may cost pharma firms Rs 3,000 crore:Industry"The IPA estimates that domestic price reductions alone will result in aggregate loss of sales of nearly Rs 3,000 crore, to the industry," ...
- Insurance cannot stand in for a public healthcare systemInsurance cannot stand in for a public healthcare system for the poor. At the same time, policy must offer returns to private sector invest...
- No time frame for National Pharmaceutical Pricing Policy: Srikant Kumar JenaThe government said no time frame can be given for implementation of NPPP as it is awaiting the response from the concerned ministries and ...
- 'No time frame can be given for implementation of NPPP, 2011'Govt said no time frame can be given for implementation of draft NPPP, 2011 as it is awaiting the response from the concerned ministries an...
- Medicines' prices should not escalate, Supreme Court tells CentreSupreme Court today asked the Union government to ensure that rates do not "escalate" causing a burden on the common man.
- FDI curbs in pharma could deter MNCs: Kewal Handa, Pfizer India MDIndia's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country.
- New pharma pricing policy can lead to shortage of drugs: Sun Pharmaceuticals IndustriesSun Pharmaceuticals Industries today hit out at the proposed draft new pharma pricing policy, 2011 saying it could lead to shortage of drug...
Load More
